Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$21.2 - $31.03 $97,520 - $142,738
4,600 New
4,600 $140,000
Q2 2023

Aug 14, 2023

SELL
$25.16 - $41.38 $183,668 - $302,074
-7,300 Reduced 62.93%
4,300 $153,000
Q1 2023

May 15, 2023

SELL
$23.68 - $38.51 $49,728 - $80,871
-2,100 Reduced 15.33%
11,600 $294,000
Q4 2022

Feb 14, 2023

BUY
$28.0 - $40.56 $103,600 - $150,072
3,700 Added 37.0%
13,700 $555,000
Q3 2022

Nov 14, 2022

BUY
$29.63 - $48.31 $148,150 - $241,550
5,000 Added 100.0%
10,000 $331,000
Q2 2022

Aug 08, 2022

SELL
$27.79 - $50.61 $411,292 - $749,028
-14,800 Reduced 74.75%
5,000 $176,000
Q1 2022

May 16, 2022

BUY
$39.62 - $69.97 $332,808 - $587,748
8,400 Added 73.68%
19,800 $911,000
Q4 2021

Feb 14, 2022

BUY
$58.09 - $82.51 $69,708 - $99,012
1,200 Added 11.76%
11,400 $756,000
Q3 2021

Nov 15, 2021

BUY
$58.38 - $84.96 $326,928 - $475,775
5,600 Added 121.74%
10,200 $637,000
Q1 2021

May 17, 2021

SELL
$61.35 - $90.47 $214,725 - $316,645
-3,500 Reduced 43.21%
4,600 $305,000
Q4 2020

Feb 16, 2021

BUY
$43.82 - $85.37 $354,942 - $691,497
8,100 New
8,100 $622,000
Q3 2020

Nov 16, 2020

SELL
$33.21 - $51.27 $73,062 - $112,794
-2,200 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$26.12 - $43.27 $2,612 - $4,327
100 Added 4.76%
2,200 $95,000
Q1 2020

May 15, 2020

BUY
$20.56 - $63.12 $39,064 - $119,928
1,900 Added 950.0%
2,100 $60,000
Q4 2019

Feb 14, 2020

SELL
$28.14 - $73.01 $36,582 - $94,913
-1,300 Reduced 86.67%
200 $13,000
Q3 2019

Nov 14, 2019

SELL
$26.26 - $34.86 $23,634 - $31,374
-900 Reduced 37.5%
1,500 $42,000
Q2 2019

Aug 14, 2019

BUY
$17.43 - $28.82 $41,832 - $69,168
2,400 New
2,400 $64,000
Q1 2019

May 15, 2019

SELL
$12.05 - $20.18 $230,155 - $385,438
-19,100 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$10.74 - $19.7 $205,134 - $376,270
19,100 New
19,100 $237,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.07B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.